This most up-to-date twist from the Lykos Therapeutics saga threatens A serious overhaul of the corporation’s system and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to desire to just take the business back toward its nonprofit drug improvement roots and a more Doblinite philosophy.“There’s going to be a great de